Author | Armand Butera

Findings suggested that the goal of holistic patient care was shared by all participants, with network communication and resource transfer potentially governing access to care.

The move comes amid delays in FDA approvals for multiple JAK inhibitors for the treatment of rheumatic conditions.

The stigma surrounding gout has contributed to the general unease patients have about their condition.